Obesity-induced hyperleptinemia improves survival and immune response in a murine model of sepsis

Anesthesiology

Volumn 121, Issue 1, 2014, Pages 98-114

  Siegl, Daniel ^d   Annecke, Thorsten ^a   Johnson, Bobby L ^c   Schlag, Christian ^a   Martignoni, Andre ^a   Huber, Nadine ^b   Conzen, Peter ^a   Caldwell, Charles C ^c   Tschöp, Johannes ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY HOSPITAL ULM   (Germany)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL3 CHEMOKINE; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6; LEPTIN; TUMOR NECROSIS FACTOR ALPHA;

ABNORMALLY LOW SUBSTRATE CONCENTRATION IN BLOOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BACTERIAL COUNT; BACTERIAL LOAD; BODY MASS; BODY TEMPERATURE; BODY WEIGHT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; COLONY FORMING UNIT; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; HISTOPATHOLOGY; HORMONE ACTION; HORMONE BLOOD LEVEL; HYPERLEPTINEMIA; HYPOLEPTINEMIA; IMMUNE RESPONSE; INFLAMMATION; INNATE IMMUNITY; LEUKOCYTE ACTIVATION; LEUKOCYTE COUNT; LIPID DIET; MACROPHAGE; MALE; MONOCYTE; MOUSE; MURINE MODEL; NATURAL KILLER CELL; NEUTROPHIL CHEMOTAXIS; NEUTROPHIL COUNT; NONHUMAN; OBESITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RESPIRATORY BURST; SEPSIS; SURVIVAL; SURVIVAL RATE; SURVIVAL TIME;

ANIMALS; BODY TEMPERATURE; BRONCHOALVEOLAR LAVAGE FLUID; CECUM; COLONY COUNT, MICROBIAL; CYTOKINES; DIETARY FATS; EATING; FLOW CYTOMETRY; IMMUNITY, CELLULAR; INFLAMMATION; INJECTIONS, INTRAPERITONEAL; LEPTIN; LEUKOCYTE COUNT; LIGATION; MICE; MICE, INBRED C57BL; NEUTROPHILS; OBESITY; RESPIRATORY BURST; SEPSIS; SURVIVAL;

EID: 84902850370     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0000000000000192     Document Type: Conference Paper

References (72)

1. Misra A, Khurana L: Obesity and the metabolic syndrome in developing countries. J Clin Endocrinol Metab 2008; 93:S9-30
2. James WP: WHO recognition of the global obesity epidemic. Int J Obes (Lond) 2008; 32(suppl 7):S120-6
3. Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL, Anis AH: The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysis. BMC Public Health 2009; 9:88
4. James WP, Rigby N, Leach R: Obesity and the metabolic syndrome: The stress on society. Ann N Y Acad Sci 2006; 1083:1-10
5. Stallone DD: The influence of obesity and its treatment on the immune system. Nutr Rev 1994; 52(2 Pt 1):37-50
6. Nieman DC, Henson DA, Nehlsen-Cannarella SL, Ekkens M, Utter AC, Butterworth DE, Fagoaga OR: Influence of obesity on immune function. J Am Diet Assoc 1999; 99:294-9
7. Gottschlich MM, Mayes T, Khoury JC, Warden GD: Significance of obesity on nutritional, immunologic, hormonal, and clinical outcome parameters in burns. J Am Diet Assoc 1993; 93:1261-8
8. Martí A, Marcos A, Martínez JA: Obesity and immune function relationships. Obes Rev 2001; 2:131-40
9. Smith AG, Sheridan PA, Harp JB, Beck MA: Diet-induced obese mice have increased mortality and altered immune responses when infected with influenza virus. J Nutr 2007; 137:1236-43
10. Saillan-Barreau C, Cousin B, André M, Villena P, Casteilla L, Pénicaud L: Human adipose cells as candidates in defense and tissue remodeling phenomena. Biochem Biophys Res Commun 2003; 309:502-5
11. Falagas ME, Kompoti M: Obesity and infection. Lancet Infect Dis 2006; 6:438-46
12. Robertson CM, Coopersmith CM: The systemic inflammatory response syndrome. Microbes Infect 2006; 8:1382-9
13. Hotchkiss RS, Karl IE: The pathophysiology and treatment of sepsis. N Engl J Med 2003; 348:138-50
14. Rivers EP, Katranji M, Jaehne KA, Brown S, Abou Dagher G, Cannon C, Coba V: Early interventions in severe sepsis and septic shock: A review of the evidence one decade later. Minerva Anestesiol 2012; 78:712-24
15. Jaeschke RZ, Brozek JL, Dellinger RP: 2008 update of international guidelines for the management of severe sepsis and septic shock: Should we change our current clinical practice? Pol Arch Med Wewn 2008; 118:92-5
16. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S, Kern PA, Friedman JM: Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1995; 1:1155-61
17. Tilg H, Moschen AR: Adipocytokines: Mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006; 6:772-83
18. Tschöp J, Dattilo JR, Prakash PS, Kasten KR, Tschöp MH, Caldwell CC: The leptin system: A potential target for sepsis induced immune suppression. Endocr Metab Immune Disord Drug Targets 2010; 10:336-47
19. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM: Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372:425-32
20. Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, Collins F: Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995; 269:540-3
21. Friedman JM: The function of leptin in nutrition, weight, and physiology. Nutr Rev 2002; 60:S1-14; discussion S68-84, 85-7
22. Santos-Alvarez J, Goberna R, Sánchez-Margalet V: Human leptin stimulates proliferation and activation of human circulating monocytes. Cell Immunol 1999; 194:6-11
23. Lord GM, Matarese G, Howard JK, Baker RJ, Bloom SR, Lechler RI: Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 1998; 394:897-901
24. Howard JK, Lord GM, Matarese G, Vendetti S, Ghatei MA, Ritter MA, Lechler RI, Bloom SR: Leptin protects mice from starvation-induced lymphoid atrophy and increases thymic cellularity in ob/ob mice. J Clin Invest 1999; 104:1051-9
25. Bornstein SR, Licinio J, Tauchnitz R, Engelmann L, Negrão AB, Gold P, Chrousos GP: Plasma leptin levels are increased in survivors of acute sepsis: Associated loss of diurnal rhythm, in cortisol and leptin secretion. J Clin Endocrinol Metab 1998; 83:280-3
26. Bracho-Riquelme RL, Reyes-Romero MA, Pescador N, Flores-García AI: A leptin serum concentration less than 10 ng/ml is a predictive marker of outcome in patients with moderate to severe secondary peritonitis. Eur Surg Res 2008; 41:238-44
27. Tschöp J, Nogueiras R, Haas-Lockie S, Kasten KR, Castañeda TR, Huber N, Guanciale K, Perez-Tilve D, Habegger K, Ottaway N, Woods SC, Oldfield B, Clarke I, Chua S Jr, Farooqi IS, O'Rahilly S, Caldwell CC, Tschöp MH: CNS leptin action modulates immune response and survival in sepsis. J Neurosci 2010; 30:6036-47
28. Madiehe AM, Mitchell TD, Harris RB: Hyperleptinemia and reduced TNF-alpha secretion cause resistance of db/db mice to endotoxin. Am J Physiol Regul Integr Comp Physiol 2003; 284:R763-70
29. Soliman M, Abdelhady S, Fattouh I, Ishioka K, Kitamura H, Kimura K, Saito M: No alteration in serum leptin levels during acute endotoxemia in sheep. J Vet Med Sci 2001; 63:1143-5
30. Harden LM, du Plessis I, Poole S, Laburn HP: Interleukin-6 and leptin mediate lipopolysaccharide-induced fever and sickness behavior. Physiol Behav 2006; 89:146-55
31. Bornstein SR, Preas HL, Chrousos GP, Suffredini AF: Circulating leptin levels during acute experimental endotoxemia and antiinflammatory therapy in humans. J Infect Dis 1998; 178:887-90
32. Shapiro NI, Khankin EV, Van Meurs M, Shih SC, Lu S, Yano M, Castro PR, Maratos-Flier E, Parikh SM, Karumanchi SA, Yano K: Leptin exacerbates sepsis-mediated morbidity and mortality. J Immunol 2010; 185:517-24
33. Murphey ED, Lin CY, McGuire RW, Toliver-Kinsky T, Herndon DN, Sherwood ER: Diminished bacterial clearance is associated with decreased IL-12 and interferon-gamma production but a sustained proinflammatory response in a murine model of postseptic immunosuppression. Shock 2004; 21:415-25
34. Henry BA, Goding JW, Alexander WS, Tilbrook AJ, Canny BJ, Dunshea F, Rao A, Mansell A, Clarke IJ: Central administration of leptin to ovariectomized ewes inhibits food intake without affecting the secretion of hormones from the pituitary gland: Evidence for a dissociation of effects on appetite and neuroendocrine function. Endocrinology 1999; 140:1175-82
35. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL: Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996; 334:292-5
36. Pittet D, Thiévent B, Wenzel RP, Li N, Auckenthaler R, Suter PM: Bedside prediction of mortality from bacteremic sepsis. A dynamic analysis of ICU patients. Am J Respir Crit Care Med 1996; 153:684-93
37. Lee WL, Harrison RE, Grinstein S: Phagocytosis by neutrophils. Microbes Infect 2003; 5:1299-306
38. Taniguchi T, Koido Y, Aiboshi J, Yamashita T, Suzaki S, Kurokawa A: Change in the ratio of interleukin-6 to interleukin-10 predicts a poor outcome in patients with systemic inflammatory response syndrome. Crit Care Med 1999; 27:1262-4
39. Flierl MA, Rittirsch D, Gao H, Hoesel LM, Nadeau BA, Day DE, Zetoune FS, Sarma JV, Huber-Lang MS, Ferrara JL, Ward PA: Adverse functions of IL-17A in experimental sepsis. FASEB J 2008; 22:2198-205
40. Neville AL, Brown CV, Weng J, Demetriades D, Velmahos GC: Obesity is an independent risk factor of mortality in severely injured blunt trauma patients. Arch Surg 2004; 139:983-7
41. Yaegashi M, Jean R, Zuriqat M, Noack S, Homel P: Outcome of morbid obesity in the intensive care unit. J Intensive Care Med 2005; 20:147-54
42. Bercault N, Boulain T, Kuteifan K, Wolf M, Runge I, Fleury JC: Obesity-related excess mortality rate in an adult intensive care unit: A risk-adjusted matched cohort study. Crit Care Med 2004; 32:998-1003
43. Tremblay A, Bandi V: Impact of body mass index on outcomes following critical care. Chest 2003; 123:1202-7
44. Giles KA, Hamdan AD, Pomposelli FB, Wyers MC, Siracuse JJ, Schermerhorn ML: Body mass index: Surgical site infections and mortality after lower extremity bypass from the National Surgical Quality Improvement Program 2005-2007. Ann Vasc Surg 2010; 24:48-56
45. Ray DE, Matchett SC, Baker K, Wasser T, Young MJ: The effect of body mass index on patient outcomes in a medical ICU. Chest 2005; 127:2125-31
46. Mica L, Vomela J, Keel M, Trentz O: The impact of body mass index on the development of systemic inflammatory response syndrome and sepsis in patients with polytrauma. Injury 2014; 45:253-8
47. Kim KA, Gu W, Lee IA, Joh EH, Kim DH: High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway. PLoS One 2012; 7:e47713
48. Ahima RS, Flier JS: Leptin. Annu Rev Physiol 2000; 62:413-37
49. Tschöp J, Martignoni A, Goetzman HS, Choi LG, Wang Q, Noel JG, Ogle CK, Pritts TA, Johannigman JA, Lentsch AB, Caldwell CC: Gammadelta T cells mitigate the organ injury and mortality of sepsis. J Leukoc Biol 2008; 83:581-8
50. Giamarellos-Bourboulis EJ, Tsaganos T, Spyridaki E, Mouktaroudi M, Plachouras D, Vaki I, Karagianni V, Antonopoulou A, Veloni V, Giamarellou H: Early changes of CD4-positive lymphocytes and NK cells in patients with severe Gram-negative sepsis. Crit Care 2006; 10:R166
51. Zhao Y, Sun R, You L, Gao C, Tian Z: Expression of leptin receptors and response to leptin stimulation of human natural killer cell lines. Biochem Biophys Res Commun 2003; 300:247-52
52. Caspar-Bauguil S, Cousin B, Galinier A, Segafredo C, Nibbelink M, André M, Casteilla L, Pénicaud L: Adipose tissues as an ancestral immune organ: Site-specific change in obesity. FEBS Lett 2005; 579:3487-92
53. Caspar-Bauguil S, Cousin B, André M, Nibbelink M, Galinier A, Periquet B, Casteilla L, Pénicaud L: Weight-dependent changes of immune system in adipose tissue: Importance of leptin. Exp Cell Res 2006; 312:2195-202
54. Wilson CA, Bekele G, Nicolson M, Ravussin E, Pratley RE: Relationship of the white blood cell count to body fat: Role of leptin. Br J Haematol 1997; 99:447-51
55. Tian Z, Sun R, Wei H, Gao B: Impaired natural killer (NK) cell activity in leptin receptor deficient mice: Leptin as a critical regulator in NK cell development and activation. Biochem Biophys Res Commun 2002; 298:297-302
56. Faggioni R, Jones-Carson J, Reed DA, Dinarello CA, Feingold KR, Grunfeld C, Fantuzzi G: Leptin-deficient (ob/ob) mice are protected from T cell-mediated hepatotoxicity: Role of tumor necrosis factor alpha and IL-18. Proc Natl Acad Sci U S A 2000; 97:2367-72
57. Malech HL, Gallin JI: Current concepts: Immunology. Neutrophils in human diseases. N Engl J Med 1987; 317:687-94
58. Craciun FL, Schuller ER, Remick DG: Early enhanced local neutrophil recruitment in peritonitis-induced sepsis improves bacterial clearance and survival. J Immunol 2010; 185:6930-8
59. Otsuka Y, Nagano K, Nagano K, Hori K, Oh-ishi J, Hayashi H, Watanabe N, Niitsu Y: Inhibition of neutrophil migration by tumor necrosis factor. Ex vivo and in vivo studies in comparison with in vitro effect. J Immunol 1990; 145:2639-43
60. Tavares-Murta BM, Cunha FQ, Ferreira SH: The intravenous administration of tumor necrosis factor alpha, interleukin 8 and macrophage-derived neutrophil chemotactic factor inhibits neutrophil migration by stimulating nitric oxide production. Br J Pharmacol 1998; 124:1369-74
61. Caldefie-Chezet F, Poulin A, Vasson MP: Leptin regulates functional capacities of polymorphonuclear neutrophils. Free Radic Res 2003; 37:809-14
62. Kaplan JM, Nowell M, Lahni P, O'Connor MP, Hake PW, Zingarelli B: Short-term high fat feeding increases organ injury and mortality after polymicrobial sepsis. Obesity (Silver Spring) 2012; 20:1995-2002
63. Jampel HD, Duff GW, Gershon RK, Atkins E, Durum SK: Fever and immunoregulation. III. Hyperthermia augments the primary in vitro humoral immune response. J Exp Med 1983; 157:1229-38
64. Marik PE, Zaloga GP: Hypothermia and cytokines in septic shock. Norasept II Study Investigators. North American study of the safety and efficacy of murine monoclonal antibody to tumor necrosis factor for the treatment of septic shock. Intensive Care Med 2000; 26:716-21
65. Rothwell NJ: CNS regulation of thermogenesis. Crit Rev Neurobiol 1994; 8:1-10
66. Luheshi GN, Gardner JD, Rushforth DA, Loudon AS, Rothwell NJ: Leptin actions on food intake and body temperature are mediated by IL-1. Proc Natl Acad Sci U S A 1999; 96:7047-52
67. Brennan AM, Mantzoros CS: Drug Insight: The role of leptin in human physiology and pathophysiology - Emerging clinical applications. Nat Clin Pract Endocrinol Metab 2006; 2:318-27
68. Harris RB, Zhou J, Redmann SM Jr, Smagin GN, Smith SR, Rodgers E, Zachwieja JJ: A leptin dose-response study in obese (ob/ob) and lean (+/-) mice. Endocrinology 1998; 139:8-19
69. Wang H, Ma S: The cytokine storm and factors determining the sequence and severity of organ dysfunction in multiple organ dysfunction syndrome. Am J Emerg Med 2008; 26:711-5
70. Okusawa S, Gelfand JA, Ikejima T, Connolly RJ, Dinarello CA: Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition. J Clin Invest 1988; 81:1162-72
71. Bahrami S, Yao YM, Leichtfried G, Redl H, Marzi I, Schlag G: Significance of TNF in hemorrhage-related hemodynamic alterations, organ injury, and mortality in rats. Am J Physiol 1997; 272(5 Pt 2):H2219-26
72. Takahashi N, Waelput W, Guisez Y: Leptin is an endogenous protective protein against the toxicity exerted by tumor necrosis factor. J Exp Med 1999; 189:207-12